Sandra Chan

Vice President
Sandra Chan | Antitrust Competition | Charles River Associates

Sandra Chan leads CRA’s Second Request and Cloud Computing/Big Data services within the firm’s Antitrust & Competition Practice. With more than 20 years of experience, she advises law firms, in-house legal teams, and corporate clients on the economics of antitrust liability, damages, mergers and acquisitions, and regulatory reviews.

Ms. Chan specializes in healthcare competition issues involving hospitals, physician groups, health insurers, and other healthcare providers. She leads teams analyzing large healthcare claims data (e.g., data from health plans, hospitals, physician groups, etc.) and government healthcare datasets (e.g., state hospital discharge data, state all-payers claims data, and Centers for Medicare & Medicaid Services data). Her experience also spans the entertainment, retail, manufacturing, and technology sectors.

Ms. Chan helps clients obtain FTC and DOJ clearance for proposed US mergers and acquisitions. She directs economic analyses of product and geographic market definition, market concentration and competitive intensity, entry, efficiencies, and horizontal and vertical competitive effects. She also streamlines the Second Request process to achieve substantial compliance efficiently and leverages resulting data to support advocacy in merger reviews and antitrust investigations.

As the leader of the practice’s cloud computing and big data team, Ms. Chan oversees the infrastructure and analytical approaches needed to process large and complex datasets efficiently, enabling timely analyses and solutions to clients.

Selected engagements

  • 01
    CRA Competition advises on Paramount acquisition of Warner Bros. Discovery
    The Department of Justice Antitrust Division reviewed the transaction that was publicly announced on February 27, 2026, with the Hart Scott Rodino waiting...
    View engagement
  • 02
    CRA Competition team advises UnitedHealth Group, clearing path for Amedisys acquisition
    The DOJ, which had initially sought to block the transaction, announced that it reached a settlement with UnitedHealth and Amedisys, enabling the deal to...
    View engagement
  • 03
    Testimony in healthcare breach of contract and damages matter
    CRA experts provided testimony in support of Steward Health Care Network’s effort to refute breach of contract, tortious interference, unfair and deceptive...
    View engagement

Credentials